BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 56 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,729 | +16.0% | 3,796,000 | +21.1% | 0.01% | +25.0% |
| Q1 2023 | $3,215 | -29.1% | 3,134,000 | -26.7% | 0.00% | -33.3% |
| Q4 2022 | $4,536 | -99.9% | 4,274,000 | -21.1% | 0.01% | -25.0% |
| Q3 2022 | $5,364,000 | +0.1% | 5,414,000 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $5,360,000 | -9.8% | 5,414,000 | -8.9% | 0.01% | +16.7% |
| Q1 2022 | $5,942,000 | -4.4% | 5,945,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $6,216,000 | -17.6% | 5,945,000 | -19.4% | 0.01% | -25.0% |
| Q3 2021 | $7,545,000 | -1.3% | 7,374,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $7,642,000 | -11.3% | 7,374,000 | -13.4% | 0.01% | -20.0% |
| Q1 2021 | $8,616,000 | -30.9% | 8,515,000 | -26.8% | 0.01% | -28.6% |
| Q4 2020 | $12,477,000 | +37.3% | 11,627,000 | +34.3% | 0.01% | +27.3% |
| Q3 2020 | $9,085,000 | +57.3% | 8,658,000 | +83.2% | 0.01% | +57.1% |
| Q2 2020 | $5,775,000 | -39.7% | 4,726,000 | -48.3% | 0.01% | -50.0% |
| Q1 2020 | $9,584,000 | -0.8% | 9,146,000 | 0.0% | 0.01% | +27.3% |
| Q4 2019 | $9,663,000 | +7.5% | 9,146,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $8,990,000 | -5.3% | 9,146,000 | 0.0% | 0.01% | -8.3% |
| Q2 2019 | $9,495,000 | +10.1% | 9,146,000 | +8.5% | 0.01% | +9.1% |
| Q1 2019 | $8,626,000 | -3.8% | 8,431,000 | -6.5% | 0.01% | -15.4% |
| Q4 2018 | $8,966,000 | – | 9,016,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
| PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
| Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
| SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
| PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
| RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
| KBC Group NV | 400,000 | $40,316,000 | 0.15% |
| PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
| MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |